Abstract We report a case of metachronous testicular seminoma occurring 8 years after treatment of extragonadal nonseminomatous germ cell tumor in the retroperitoneum. A 29-year-old male Japanese patient presented with a bulky tumor in the left obturator fossa. The serum levels of alfafetoprotein and lactate dehydrogenase were extremely high. He underwent open tumor biopsy and the pathological finding was immature teratoma. After three cycles of BEP therapy (bleomycin, etoposide, cisplatin), we performed retroperitoneal lymph node dissection and tumor resection. We added one cycle of VIP therapy (vinblastine, ifosfamide, cisplatin) as a salvage therapy because the pathological examination demonstrated immature teratoma with suspicious viable germ cell tumors. Eight years after surgery, the patient noticed that the left testis was swollen. All tumor markers were within normal limits. We performed a left radical orchiectomy, and pathological examination revealed pure seminoma with invasion of the rete testis. We emphasize the necessity of self-examination after treatment of extragonadal germ cell tumor.
Introduction
Extragonadal germ cell tumor (EGGCT) is rare and accounts for 2-5 % of cancer diagnosis in all germ cell tumors [1] . Metachronous testicular tumor after EGGCT is also rare. To the best of our knowledge, 35 cases were reported in the literature [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . Herein we report a case of metachronous testicular pure seminoma occurring 8 years after treatment of immature teratoma in the pelvis.
Case report
The patient was previously reported as a case with EGGCT arising in an unusual site [15] . He noticed left inguinal and hip pain at the age of 29 years old. Magnetic resonance imaging (MRI) showed a bulky tumor in the left obturator fossa (Fig. 1) . The size of the tumor was 10 9 6 9 10.5 cm, and the para-aortic lymph node was also swollen (4 9 3 cm). Serum levels of AFP (alpha-fetoprotein) and LDH (lactate dehydrogenase) were extremely high (12946.2 ng/ml and 508 IU/L, respectively). On the other hand, the serum level of beta human chorionic gonadotropin was within the normal limits.
Open tumor biopsy revealed it was immature teratoma (Fig. 2) . Radiographic and physical examination revealed no abnormal findings in the bilateral testes, including burnout tumor. After three cycles of BEP therapy (bleomycin, etoposide, cisplatin) and normalization of tumor markers, we performed retroperitoneal lymph node dissection and tumor resection. The pathological examination demonstrated immature teratoma with suspicious viable germ cell tumors, and the main tumor was located in an extralymphatic site. Then we added one cycle of VIP therapy (vinblastine, ifosfamide, cisplatin) as a salvage therapy.
There had been no findings suggestive of recurrence and metastasis after the initial treatment. Eight years after surgery, however, the patient noticed the left testis swollen without scrotal pain. The size of left testis was 5.5 9 3.2 cm,
Tsukamoto Department of Urology, Sapporo Medical University School of Medicine, S1W16, Chuo-ku, Sapporo 064-8543, Japan e-mail: shibamori.k@gmail.com and ultrasonography showed a heterogeneous solid mass. There was no abnormal finding in the right testis and no radiographic evidence of metastatic disease. All tumor markers were within normal limits. We performed a left radical orchiectomy, and pathological examination revealed pure seminoma with invasion of the rete testis (Fig. 3 ). After that, we added two cycles of carboplatin as adjuvant chemotherapy because we decided he was at high risk of developing recurrence. He was free from disease 10 months after surgery.
Discussion
Metachronous testicular tumor after EGGCT is rare. To the best of our knowledge, 35 cases were reported in the literature, as summarized in Table 1 [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . Hartmann et al. [8] reported that the cumulative risk for development of metachronous testicular cancer 10 years after diagnosis of EGGCT is 10.3 %. Also they reported that metachronous testicular cancer occurred in 14.2 % of retroperitoneal EGGCT and 6.2 % of mediastinal EGGCT cases. The cumulative risk of seminomatous EGGCT was 1.4 %, whereas that of nonseminomatous EGGCT was 14.3 %.
It is controversial whether EGGCT is a primary tumor or metastasis of testicular intraepithelial neoplasia (TIN). We did not perform testis biopsy when he developed EGGCT. He might have had TIN in the left testis and presented with a late relapse this time. In our patient, however, microscopic examination revealed that the tumor in the pelvis grew outside the lymphatic tissue, whereas the left obturator lymph node did not contain the tumor tissue. This finding suggested that the pelvic tumor was of extragonadal origin rather than the result of lymph node metastasis. Therefore, we concluded that the testicular seminoma was a metachronous tumor.
Interestingly, the combination of nonseminomatous EGGCT and metachronous seminoma, similar to our case, was the most common in the reported cases. The mechanism of the trend to develop this combination is unclear. Oosterhuis et al. [16, 17] showed that the primitive germ cell tumor could differentiate into seminoma, and seminoma could differentiate into nonseminoma in stages. We hypothesized that EGGCT would be asymptomatic until it grew bulky because of its development deep in the body, so that it would tend to differentiate into nonseminoma at the time of diagnosis. On the other hand, MTT would be detected more easily in the early period because it is palpable in the scrotum and would be noticed in the follow-up for EGGCT. In this case, although serum AFP levels were extremely elevated, open biopsy revealed no component other than immature teratoma. The tumor possibly had components of embryonal carcinoma or a yolk sac tumor that were not detected by sampling. Furthermore, the necessity for an appropriate regimen of salvage chemotherapy for patients with immature teratoma only proven in the residual mass had not been established at that time. Recently, two cycles of cisplatin-based chemotherapy were recommended for patients with proven viable cancer cells or immature teratoma found by residual mass resection [18] . However, the number of cycles was determined empirically [19] and is not well validated. Although we performed only one cycle of VIP therapy, the treatment strategy may not have affected the metachronous recurrence in this case.
Given that patients with germ cell tumors have a high risk of metachronous testicular tumor [8] , we emphasize the necessity of self-examination of the testes as well as long-term follow-up with both physical and tumor marker examinations by medical doctors after treatment of EGGCT.
